A137310 Stock Overview
An in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
SD Biosensor, Inc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩10,210.00 |
| 52 Week High | ₩15,340.00 |
| 52 Week Low | ₩7,870.00 |
| Beta | 0.95 |
| 11 Month Change | 13.82% |
| 3 Month Change | -11.29% |
| 1 Year Change | -6.76% |
| 33 Year Change | -80.74% |
| 5 Year Change | n/a |
| Change since IPO | -83.26% |
Recent News & Updates
What SD Biosensor, Inc's (KRX:137310) 25% Share Price Gain Is Not Telling You
Aug 24
Would SD Biosensor (KRX:137310) Be Better Off With Less Debt?
Aug 08Insufficient Growth At SD Biosensor, Inc (KRX:137310) Hampers Share Price
Jul 03Recent updates
What SD Biosensor, Inc's (KRX:137310) 25% Share Price Gain Is Not Telling You
Aug 24Would SD Biosensor (KRX:137310) Be Better Off With Less Debt?
Aug 08Insufficient Growth At SD Biosensor, Inc (KRX:137310) Hampers Share Price
Jul 03Insufficient Growth At SD Biosensor, Inc (KRX:137310) Hampers Share Price
Feb 28Shareholder Returns
| A137310 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 13.8% | 9.4% | 2.3% |
| 1Y | -6.8% | 12.3% | -3.8% |
Return vs Industry: A137310 underperformed the KR Medical Equipment industry which returned 12.3% over the past year.
Return vs Market: A137310 underperformed the KR Market which returned -3.8% over the past year.
Price Volatility
| A137310 volatility | |
|---|---|
| A137310 Average Weekly Movement | 6.5% |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.4% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A137310 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A137310's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 576 | Hyo Keun Lee | www.sdbiosensor.com |
SD Biosensor, Inc, an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company’s products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decision making near-the-patient, which include analyzers, assay menus, qPCR reagents, and NA extraction kits; procell Dx, an in vitro diagnostic products for the diagnosis of infectious disease, such as tuberculosis and SARS-CoV-2, and for checking the immune status of individuals through the interferon gamma release assay; and blood glucose meters.
SD Biosensor, Inc Fundamentals Summary
| A137310 fundamental statistics | |
|---|---|
| Market cap | ₩1.25t |
| Earnings (TTM) | -₩63.22b |
| Revenue (TTM) | ₩674.07b |
1.9x
P/S Ratio-19.8x
P/E RatioIs A137310 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A137310 income statement (TTM) | |
|---|---|
| Revenue | ₩674.07b |
| Cost of Revenue | ₩352.29b |
| Gross Profit | ₩321.77b |
| Other Expenses | ₩384.99b |
| Earnings | -₩63.22b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -516.71 |
| Gross Margin | 47.74% |
| Net Profit Margin | -9.38% |
| Debt/Equity Ratio | 17.4% |
How did A137310 perform over the long term?
See historical performance and comparison